Mirmur
New member
- Joined
- Mar 8, 2010
- Messages
- 22
- Reaction score
- 0
- Points
- 1
Slow release antibiotics for treatment of septic arthritis in large animals
The Veterinary Journal, Volume 184, Issue 1, April 2010, Pages 14-20
M. Christina Haerdi-Landerer, Judith Habermacher, Barbara Wenger, Maja M. Suter, Adrian Steiner
http://www.elib4vet.com/newthread.php?do=newthread&f=57The search for an effective treatment for septic arthritis is ongoing. Current therapies are expensive since they require repeated joint lavage and long term antibiotic treatment. Local application of antimicrobial drugs is advantageous because high concentrations can be attained at the infection site, although repeated injections increase the risk of superinfection of the joint. Thus, slow release formulations, which have the advantage of local treatment yet single application of the drug, are appealing. Antibiotics used in slow release formulations are selected for tissue compatibility, an appropriate antibacterial spectrum, and stability both during the mixing procedure and within the carrier during the release period. Ideally the carriers should be bioresorbable. Promising reports on the clinical use of poly(methyl methacrylate) (PMMA) mixed with several different antibiotics, and of collagen sponges impregnated with gentamicin, should encourage the search for formulations optimally adapted to veterinary medical requirements.
The Veterinary Journal, Volume 184, Issue 1, April 2010, Pages 14-20
M. Christina Haerdi-Landerer, Judith Habermacher, Barbara Wenger, Maja M. Suter, Adrian Steiner
http://www.elib4vet.com/newthread.php?do=newthread&f=57The search for an effective treatment for septic arthritis is ongoing. Current therapies are expensive since they require repeated joint lavage and long term antibiotic treatment. Local application of antimicrobial drugs is advantageous because high concentrations can be attained at the infection site, although repeated injections increase the risk of superinfection of the joint. Thus, slow release formulations, which have the advantage of local treatment yet single application of the drug, are appealing. Antibiotics used in slow release formulations are selected for tissue compatibility, an appropriate antibacterial spectrum, and stability both during the mixing procedure and within the carrier during the release period. Ideally the carriers should be bioresorbable. Promising reports on the clinical use of poly(methyl methacrylate) (PMMA) mixed with several different antibiotics, and of collagen sponges impregnated with gentamicin, should encourage the search for formulations optimally adapted to veterinary medical requirements.
